EUROPEAN MEDICAL SOLUTIONS S (ALEMS.BR) Stock Price, Forecast & Analysis
Europe - Euronext Brussels - EBR:ALEMS - BE0974497290 - Common Stock
ALEMS.BR Key Statistics, Chart & Performance
The current stock price of ALEMS.BR is 5.12 EUR. In the past month the price increased by 5.57%. In the past year, price decreased by -27.27%.
ALEMS.BR Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| 1AE.DE | ARGENX SE | 68.21 | 44.30B | ||
| ARGX.BR | ARGENX SE | 68.11 | 44.24B | ||
| 22UA.DE | BIONTECH SE-ADR | N/A | 18.82B | ||
| ABVX.PA | ABIVAX SA | N/A | 9.50B | ||
| 2X1.DE | ABIVAX SA | N/A | 9.31B | ||
| GLPG.AS | GALAPAGOS NV | N/A | 1.84B | ||
| GXE.DE | GALAPAGOS NV | N/A | 1.84B | ||
| NANO.PA | NANOBIOTIX | N/A | 950.81M | ||
| 5CV.DE | CUREVAC NV | 6.1 | 796.20M | ||
| IVA.PA | INVENTIVA SA | N/A | 718.23M | ||
| PHIL.MI | PHILOGEN SPA | 20.53 | 684.22M | ||
| FYB.DE | FORMYCON AG | N/A | 439.10M |
Related stock screener links
About ALEMS.BR
Company Profile
European Medical Solutions is a clinical stage biopharmaceutical company, which engages in the research and development of immunotherapy treatments for environmental and food allergies. The company is headquartered in Brussels, Bruxelles-Capitale and currently employs 123 full-time employees. The company went IPO on 2016-05-11. The firm offers a complete range of medical imaging systems on the international market. The company is engaged in the design and manufacturing of imaging systems for digital and conventional radiology and bone densitometry. The company offers products such as: X-ray equipment (mobile X-ray units, floating panel tables, movable poles for operating theatres, etc. ), ultrasonic bone densitometers (for the reconstruction of bone microarchitecture), X-ray bone densitometers (for bone density measurement), etc.
Company Info
EUROPEAN MEDICAL SOLUTIONS S
Avenue Louise 231
Brussels BRUXELLES-CAPITALE BE
Employees: 123
Phone: 32467504900
EUROPEAN MEDICAL SOLUTIONS S / ALEMS.BR FAQ
What does ALEMS do?
European Medical Solutions is a clinical stage biopharmaceutical company, which engages in the research and development of immunotherapy treatments for environmental and food allergies. The company is headquartered in Brussels, Bruxelles-Capitale and currently employs 123 full-time employees. The company went IPO on 2016-05-11. The firm offers a complete range of medical imaging systems on the international market. The company is engaged in the design and manufacturing of imaging systems for digital and conventional radiology and bone densitometry. The company offers products such as: X-ray equipment (mobile X-ray units, floating panel tables, movable poles for operating theatres, etc. ), ultrasonic bone densitometers (for the reconstruction of bone microarchitecture), X-ray bone densitometers (for bone density measurement), etc.
Can you provide the latest stock price for EUROPEAN MEDICAL SOLUTIONS S?
The current stock price of ALEMS.BR is 5.12 EUR. The price increased by 10.81% in the last trading session.
What is the dividend status of EUROPEAN MEDICAL SOLUTIONS S?
ALEMS.BR does not pay a dividend.
What is the ChartMill rating of EUROPEAN MEDICAL SOLUTIONS S stock?
ALEMS.BR has a ChartMill Technical rating of 3 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
What is EUROPEAN MEDICAL SOLUTIONS S worth?
EUROPEAN MEDICAL SOLUTIONS S (ALEMS.BR) has a market capitalization of 21.66M EUR. This makes ALEMS.BR a Nano Cap stock.
ALEMS.BR Technical Analysis
ChartMill assigns a technical rating of 3 / 10 to ALEMS.BR. When comparing the yearly performance of all stocks, ALEMS.BR is a bad performer in the overall market: 90.27% of all stocks are doing better.
ALEMS.BR Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to ALEMS.BR. ALEMS.BR has a medium profitability rating, but doesn't score so well on its financial health evaluation.
ALEMS.BR Financial Highlights
Over the last trailing twelve months ALEMS.BR reported a non-GAAP Earnings per Share(EPS) of 0.27. The EPS increased by 4809.09% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 2.5% | ||
| ROA | 2.25% | ||
| ROE | 10.64% | ||
| Debt/Equity | 1.24 |